| Bioactivity | (Rac)-D3S-001 is the racemate of D3S-001 (HY-160866)[1]. |
| CAS | 2706637-43-4 |
| Formula | C32H35F6N7O3 |
| Molar Mass | 679.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang J, et al. D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities. Cancer Discov. 2024 May 8. [2]. Zhang yang, et al.Pyrimidoheterocyclic compounds and application thereof. Patent. WO2021180181 |